First Tracks Biotherapeutics, Inc. (TRAX)
NASDAQ: TRAX · Real-Time Price · USD
20.05
+1.95 (10.77%)
At close: Apr 28, 2026, 4:00 PM EDT
19.56
-0.49 (-2.44%)
After-hours: Apr 28, 2026, 7:58 PM EDT
TRAX Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Cost of Revenue | 139.61 | 152.35 | - |
| Gross Profit | -139.61 | -152.35 | - |
| Selling, General & Admin | 39.39 | 28.76 | 20.87 |
| Research & Development | - | - | 90.26 |
| Operating Expenses | 39.39 | 28.76 | 111.12 |
| Operating Income | -179.01 | -181.1 | -111.12 |
| Interest & Investment Income | 12.94 | 17.38 | 12.31 |
| Other Non Operating Income (Expenses) | -0.02 | 0.01 | -0 |
| EBT Excluding Unusual Items | -166.09 | -163.71 | -98.81 |
| Pretax Income | -166.09 | -163.71 | -106.15 |
| Net Income | -166.09 | -163.71 | -106.15 |
| Net Income to Common | -166.09 | -163.71 | -106.15 |
| Free Cash Flow | -143.01 | -126.16 | -93.81 |
| EBITDA | -178.45 | -180.5 | -110.47 |
| D&A For EBITDA | 0.56 | 0.61 | 0.65 |
| EBIT | -179.01 | -181.1 | -111.12 |
Source: S&P Capital IQ. Standard template.
Financial Sources.